<- Go Home

Provexis plc

Provexis plc, together with its subsidiaries, develops, licenses, and sells functional foods, medical foods, and dietary supplements worldwide. The company offers syrup and powder versions of Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typically associated with cardiovascular diseases, such as heart attack and stroke used in various foods, beverages, and dietary supplement formats. It also provides Fruitflow+ Omega-3, a dietary supplement product. The company sells its products through company’s website and distributors. Provexis plc was founded in 1999 and is based in Reading, the United Kingdom.

Market Cap

GBP 14.7M

Volume

883.8K

Cash and Equivalents

GBP 708.1K

EBITDA

N/A

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

GBP 532.9K

Profit Margin

41.24%

52 Week High

GBP 0.01

52 Week Low

GBP 0.00

Dividend

N/A

Price / Book Value

11.30

Price / Earnings

-31.41

Price / Tangible Book Value

11.30

Enterprise Value

GBP 13.4M

Enterprise Value / EBITDA

N/A

Operating Income

-GBP 452.0K

Return on Equity

94.87%

Return on Assets

-37.41

Cash and Short Term Investments

GBP 708.1K

Debt

N/A

Equity

GBP 763.8K

Revenue

GBP 1.3M

Unlevered FCF

-GBP 168.7K

Sector

Personal Care Products

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches